@article{larochelle_intolerance_2025,

title = {Intolerance of Uncertainty and Emotion Dysregulation as Predictors of Generalized Anxiety Disorder Severity in a Clinical Population},

author = {S. Larochelle and M. J. Dugas and F. Langlois and P. Gosselin and G. Belleville and S. Bouchard},

url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-86000587548&doi=10.3390%2Fjcm14051502&partnerID=40&md5=7a364fe831d85eff0f0f7121657649e5},

doi = {10.3390/jcm14051502},

issn = {20770383 (ISSN)},

year  = {2025},

date = {2025-01-01},

journal = {Journal of Clinical Medicine},

volume = {14},

number = {5},

abstract = {Background/objectives: Several factors have been shown to play a role in the development and maintenance of generalized anxiety disorder (GAD), including intolerance of uncertainty and emotion dysregulation. Although the individual contribution of both of these factors is well documented, their combined effect has yet to be studied in a clinical population with GAD. The aim of the present study was to examine the relative contribution of intolerance of uncertainty and emotion dysregulation to the prediction of worry and GAD severity in adults with GAD. Methods: The sample consisted of 108 participants diagnosed with GAD. The participants completed measures of worry, GAD severity, depressive symptoms, intolerance of uncertainty, and emotion dysregulation. Results: Multiple regression indicated that both intolerance of uncertainty and emotion dysregulation significantly contributed to both worry and GAD severity, over and above the contribution of depressive symptoms. Of note, the model explained 36% of the variance in GAD severity scores. Conclusions: The present results provide preliminary evidence of complementarity among dominant models of GAD, and point to the potential role of integrative conceptualizations and treatment strategies for GAD. © 2025 by the authors.},

note = {Publisher: Multidisciplinary Digital Publishing Institute (MDPI)},

keywords = {adult, aged, article, Beck Depression Inventory, clinical population, comorbidity, controlled study, Depression, difficulties in emotion regulation scale, disease severity, emotion, emotion dysregulation, emotion regulation, employment status, female, generalized anxiety disorder, human, intolerance of uncertainty, Intolerance of Uncertainty Scale, major clinical study, male, patient worry, penn state worry questionnaire, prediction, predictive model, psychotherapy, Severity of Illness Index, sociodemographics, theoretical model},

pubstate = {published},

tppubtype = {article}

}

@article{bouchard_assessing_2025,

title = {Assessing telepresence when delivering psychotherapy in videoconference: relevance and test-retest reliability of the Telepresence Videoconference Scale},

author = {S. Bouchard and C. Torres Pessanha and K. H. Tober},

url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-105023903509&partnerID=40&md5=46afce3aea732a9501fc3a1096d67673},

issn = {15548716 (ISSN)},

year  = {2025},

date = {2025-01-01},

journal = {Annual Review of CyberTherapy and Telemedicine},

volume = {23},

pages = {70–75},

abstract = {The increasing use of psychotherapy delivered via videoconference requires sound methods to assess clients' subjective experiences. Telepresence, defined as the feeling of being together in an online session despite the actual physical distance, is receiving increased attention as an important concept. The Telepresence in Videoconference Scale (TVS) assesses client telepresence during psychotherapy sessions and has been initially validated. However, its stability across sessions and its independence from the concept of treatment satisfaction need further evaluation. This paper presents an overview of studies using the TVS and examines the psychometric properties of the TVS in 65 adults (mean age = 39.9},

keywords = {adult, agoraphobia, article, Client Satisfaction Questionnaire, cognitive behavioral therapy, discriminant validity, female, generalized anxiety disorder, human, major clinical study, male, panic, Patient Satisfaction, psychological rating scale, psychotherapy, questionnaire, social interaction, Telemedicine, telepresence, Telepresence in Videoconference Scale, Telepresence Videoconference Scale, telepsychotherapy, test retest reliability, Test-retest reliability, videoconference, videoconferencing},

pubstate = {published},

tppubtype = {article}

}

@article{cipolletta_validation_2024,

title = {Validation of the Italian Version of the Telepresence in Videoconference Scale (TVS) in a Sample of Psychologists and Psychotherapists During the COVID-19 Pandemic},

author = {S. Cipolletta and S. Tomaino and S. Bouchard and M. Berthiaume and G. Manzoni},

url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85195533802&doi=10.1002%2fcpp.3015&partnerID=40&md5=255de2597dc6747136150f331ae970ab},

doi = {10.1002/cpp.3015},

issn = {10633995 (ISSN)},

year  = {2024},

date = {2024-01-01},

journal = {Clinical Psychology and Psychotherapy},

volume = {31},

number = {3},

publisher = {John Wiley and Sons Ltd},

abstract = {Objective: Telepresence may play a fundamental role in establishing authentic interactions and relationships in online psychological interventions and can be measured by the Telepresence in Videoconference Scale (TVS), which was validated only with patients to date. This post hoc study aimed to validate the Italian version of the TVS with mental health professionals. Method: The Italian TVS was included in an online survey, whose primary aim was to assess the experiences of Italian psychologists and psychotherapists with online interventions during the first wave of the COVID-19 pandemic and was filled in by 296 participants (83.4% females, mean age = 42 years old). Results: Exploratory factor analysis supported the original factor structure only partially because the scale ‘Absorption’ (i.e., the feeling of losing track of time), as it was formulated, did not measure telepresence. Correlations were also explored between the TVS scales and some survey items pertaining to intimacy and emotional closeness to patients, comfort and positive as well as negative experiences with online interventions. Conclusion: The TVS may be a useful tool to measure physical and social telepresence in online interventions, both in patients and in professionals. © 2024 John Wiley & Sons Ltd.},

note = {Publisher: John Wiley and Sons Ltd},

keywords = {adult, coronavirus disease 2019, COVID-19, female, human, Humans, Italy, male, Middle Aged, online psychological interventions, pandemic, Pandemics, procedures, psychology, Psychometrics, psychometry, psychotherapist, Psychotherapists, psychotherapy, questionnaire, reproducibility, Reproducibility of Results, SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2, Surveys and Questionnaires, Telemedicine, telepresence, Validation, videoconference, videoconferencing},

pubstate = {published},

tppubtype = {article}

}

@article{cipolletta_validation_2024-1,

title = {Validation of the Italian Version of the Telepresence in Videoconference Scale (TVS) in a Sample of Psychologists and Psychotherapists During the COVID-19 Pandemic},

author = {S. Cipolletta and S. Tomaino and S. Bouchard and M. Berthiaume and G. Manzoni},

url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85195533802&doi=10.1002%2fcpp.3015&partnerID=40&md5=255de2597dc6747136150f331ae970ab},

doi = {10.1002/cpp.3015},

issn = {10633995 (ISSN)},

year  = {2024},

date = {2024-01-01},

journal = {Clinical Psychology and Psychotherapy},

volume = {31},

number = {3},

publisher = {John Wiley and Sons Ltd},

abstract = {Objective: Telepresence may play a fundamental role in establishing authentic interactions and relationships in online psychological interventions and can be measured by the Telepresence in Videoconference Scale (TVS), which was validated only with patients to date. This post hoc study aimed to validate the Italian version of the TVS with mental health professionals. Method: The Italian TVS was included in an online survey, whose primary aim was to assess the experiences of Italian psychologists and psychotherapists with online interventions during the first wave of the COVID-19 pandemic and was filled in by 296 participants (83.4% females, mean age = 42 years old). Results: Exploratory factor analysis supported the original factor structure only partially because the scale ‘Absorption’ (i.e., the feeling of losing track of time), as it was formulated, did not measure telepresence. Correlations were also explored between the TVS scales and some survey items pertaining to intimacy and emotional closeness to patients, comfort and positive as well as negative experiences with online interventions. Conclusion: The TVS may be a useful tool to measure physical and social telepresence in online interventions, both in patients and in professionals. © 2024 John Wiley & Sons Ltd.},

keywords = {adult, coronavirus disease 2019, COVID-19, female, human, Humans, Italy, male, Middle Aged, online psychological interventions, pandemic, Pandemics, procedures, psychology, Psychometrics, psychometry, psychotherapist, Psychotherapists, psychotherapy, questionnaire, reproducibility, Reproducibility of Results, SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2, Surveys and Questionnaires, Telemedicine, telepresence, Validation, videoconference, videoconferencing},

pubstate = {published},

tppubtype = {article}

}

@article{quintana_engaging_2023,

title = {Engaging in Awkward Social Interactions in a Virtual Environment Designed for Exposure-Based Psychotherapy for People with Generalized Social Anxiety Disorder: An International Multisite Study},

author = {P. Quintana and S. Bouchard and C. Botella and G. Robillard and B. Serrano and A. Rodriguez-Ortega and M. Torp Ernst and B. Rey and M. Berthiaume and G. Corno},

url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85165033932&doi=10.3390%2fjcm12134525&partnerID=40&md5=7b0f59b46ff7680611d5a64e18909651},

doi = {10.3390/jcm12134525},

issn = {20770383 (ISSN)},

year  = {2023},

date = {2023-01-01},

journal = {Journal of Clinical Medicine},

volume = {12},

number = {13},

publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},

abstract = {The effectiveness of in virtuo exposure-based treatment of performance-only social anxiety disorder (SAD) has been demonstrated in several studies. However, few studies have validated virtual environments with participants suffering from generalized SAD. The goal of this study is to confirm the potential of a virtual environment in inducing anxiety in adults suffering from generalized SAD, compared to adults without SAD, when engaged in awkward social interactions. Differences between participants from two different countries were also explored. The sample consisted of 15 participants with SAD from Canada, 17 participants without SAD from Canada, 16 participants with SAD from Spain, and 21 participants without SAD from Spain. All participants were immersed in a control virtual environment and in an experimental virtual environment considered potentially anxiety-inducing for individuals with generalized SAD. As hypothesized, results showed that the experimental virtual environment induced a higher level of anxiety than the control environment among participants with SAD compared to those without SAD. The impact on anxiety of each socially threatening task performed during the experimental immersion was statistically significant. In terms of anxiety responses, no significant differences were found between participants from Canada and Spain. However, spatial presence and ecological validity were higher in Canadians than in Spaniards. Unwanted negative side effects induced by immersions in virtual reality were higher in the SAD group. This study highlights the importance for therapists to engage people with SAD in clinically relevant tasks while immersed in VR psychotherapeutic applications. © 2023 by the authors.},

note = {Publisher: Multidisciplinary Digital Publishing Institute (MDPI)},

keywords = {adult, anxiety assessment, article, Canada, clinical article, controlled study, cultural differences, ecological validity, exposure, female, generalized social anxiety, human, immersion, male, multicenter study, psychotherapy, self report, social anxiety, social interaction, social phobia, Spain, virtual reality, virtual reality exposure therapy},

pubstate = {published},

tppubtype = {article}

}

@article{ma_integrating_2021,

title = {Integrating virtual realities and psychotherapy: SWOT analysis on VR and MR based treatments of anxiety and stress-related disorders},

author = {L. Ma and S. Mor and P. L. Anderson and R. M. Baños and C. Botella and S. Bouchard and G. Cárdenas-López and T. Donker and J. Fernández-Álvarez and P. Lindner and A. Mühlberger and M. B. Powers and S. Quero and B. Rothbaum and B. K. Wiederhold and P. Carlbring},

url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85111974867&doi=10.1080%2f16506073.2021.1939410&partnerID=40&md5=37846f3bc3b9b7e260efba2709cb3c7b},

doi = {10.1080/16506073.2021.1939410},

issn = {16506073},

year  = {2021},

date = {2021-01-01},

journal = {Cognitive Behaviour Therapy},

volume = {50},

number = {6},

pages = {509–526},

publisher = {Routledge},

abstract = {The use of virtual reality (VR) and mixed reality (MR) technology in clinical psychology is growing. Efficacious VR-based treatments for a variety of disorders have been developed. However, the field of technology-assisted psychotherapy is constantly changing with the advancement in technology. Factors such as interdisciplinary collaboration, consumer familiarity and adoption of VR products, and progress in clinical science all need to be taken into consideration when integrating virtual technologies into psychotherapies. We aim to present an overview of current expert opinions on the use of virtual technologies in the treatment of anxiety and stress-related disorders. An anonymous survey was distributed to a select group of researchers and clinicians, using an analytic framework known as Strengths, Weaknesses, Opportunities, and Threats (SWOT). Overall, the respondents had an optimistic outlook regarding the current use as well as future development and implementation of technology-assisted interventions. VR and MR psychotherapies offer distinct advantages that can overcome shortcomings associated with traditional therapy. The respondents acknowledged and discussed current limitations of VR and MR psychotherapies. They recommended consolidation of existing knowledge and encouraged standardisation in both theory and practice. Continued research is needed to leverage the strengths of VR and MR to develop better treatments. Abbreviations: AR: Augmented Reality; MR: Mixed Reality; RCT: Randomised Controlled Trial; SWOT: Strengths, Weaknesses, Opportunities, and Threats; VR: Virtual Reality; VR-EBT: Virtual Reality Exposure-Based Therapy. © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.},

note = {Publisher: Routledge},

keywords = {Anxiety, Anxiety disorder, Anxiety Disorders, augmented reality, health care survey, Health Care Surveys, human, Humans, mental stress, Psychological, psychology, Psychotherapists, psychotherapy, Stress, virtual reality},

pubstate = {published},

tppubtype = {article}

}

@article{guitard_exposure_2019,

title = {Exposure to a standardized catastrophic scenario in virtual reality or a personalized scenario in imagination for Generalized Anxiety Disorder},

author = {T. Guitard and S. Bouchard and C. Bélanger and M. Berthiaume},

url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073896961&doi=10.3390%2fjcm8030309&partnerID=40&md5=b80f2e6602416c35dd8e36fd8b19c803},

doi = {10.3390/jcm8030309},

issn = {20770383 (ISSN)},

year  = {2019},

date = {2019-01-01},

journal = {Journal of Clinical Medicine},

volume = {8},

number = {3},

publisher = {MDPI},

abstract = {The cognitive behavioral treatment of generalized anxiety disorder (GAD) often involves exposing patients to a catastrophic scenario depicting their most feared worry. The aim of this study was to examine whether a standardized scenario recreated in virtual reality (VR) would elicit anxiety and negative affect and how it compared to the traditional method of imagining a personalized catastrophic scenario. A sample of 28 participants were first exposed to a neutral non-catastrophic scenario and then to a personalized scenario in imagination or a standardized virtual scenario presented in a counterbalanced order. The participants completed questionnaires before and after each immersion. The results suggest that the standardized virtual scenario induced significant anxiety. No difference was found when comparing exposure to the standardized scenario in VR and exposure to the personalized scenario in imagination. These findings were specific to anxiety and not to the broader measure of negative affect. Individual differences in susceptibility to feel present in VR was a significant predictor of increase in anxiety and negative affect. Future research could use these scenarios to conduct a randomized control trial to test the efficacy and cost/benefits of using VR in the treatment of GAD. © 2019 by the authors. Licensee MDPI, Basel, Switzerland.},

note = {Publisher: MDPI},

keywords = {adult, anxiety assessment, article, avoidance behavior, clinical article, cognitive avoidance questionnaire, cognitive behavioral therapy, Cognitive exposure, disease severity, DSM-IV, Exposure in virtual reality, fatigue, female, gatineau presence questionnaire, generalized anxiety disorder, Generalized Anxiety Disorder (GAD), human, human experiment, imagination, immersive tendencies questionnaire, Likert scale, male, Middle Aged, mini international neuropsychiatric interview, penn state worry questionnaire, Personalized scenario, Positive and Negative Affect Schedule, Positive and Negative Syndrome Scale, Presence Questionnaire, psychotherapy, questionnaire, Simulator Sickness Questionnaire, Standardized scenario, task performance, test retest reliability, time series analysis, virtual reality},

pubstate = {published},

tppubtype = {article}

}

@article{du_sert_virtual_2018,

title = {Virtual reality therapy for refractory auditory verbal hallucinations in schizophrenia: A pilot clinical trial},

author = {O. P. Sert and S. Potvin and O. Lipp and L. Dellazizzo and M. Laurelli and R. Breton and P. Lalonde and K. Phraxayavong and K. O'Connor and J. -F. Pelletier and T. Boukhalfi and P. Renaud and A. Dumais},

url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042420594&doi=10.1016%2fj.schres.2018.02.031&partnerID=40&md5=fe98669ecfdfb69d05cc9ebb58fecdcc},

doi = {10.1016/j.schres.2018.02.031},

issn = {09209964},

year  = {2018},

date = {2018-01-01},

journal = {Schizophrenia Research},

volume = {197},

pages = {176–181},

publisher = {Elsevier B.V.},

abstract = {Schizophrenia is a chronic and severe mental illness that poses significant challenges. While many pharmacological and psychosocial interventions are available, many treatment-resistant schizophrenia patients continue to suffer from persistent psychotic symptoms, notably auditory verbal hallucinations (AVH), which are highly disabling. This unmet clinical need requires new innovative treatment options. Recently, a psychological therapy using computerized technology has shown large therapeutic effects on AVH severity by enabling patients to engage in a dialogue with a computerized representation of their voices. These very promising results have been extended by our team using immersive virtual reality (VR). Our study was a 7-week phase-II, randomized, partial cross-over trial. Nineteen schizophrenia patients with refractory AVH were recruited and randomly allocated to either VR-assisted therapy (VRT) or treatment-as-usual (TAU). The group allocated to TAU consisted of antipsychotic treatment and usual meetings with clinicians. The TAU group then received a delayed 7 weeks of VRT. A follow-up was ensured 3 months after the last VRT therapy session. Changes in psychiatric symptoms, before and after TAU or VRT, were assessed using a linear mixed-effects model. Our findings showed that VRT produced significant improvements in AVH severity, depressive symptoms and quality of life that lasted at the 3-month follow-up period. Consistent with previous research, our results suggest that VRT might be efficacious in reducing AVH related distress. The therapeutic effects of VRT on the distress associated with the voices were particularly prominent (d = 1.2). VRT is a highly novel and promising intervention for refractory AVH in schizophrenia. © 2018},

note = {Publisher: Elsevier B.V.},

keywords = {adult, article, auditory hallucination, auditory verbal hallucination, clinical article, clinical effectiveness, computer assisted therapy, Computer-Assisted, controlled study, Cross-Over Studies, crossover procedure, disease severity, distress syndrome, female, follow up, Follow-Up Studies, hallucination, Hallucinations, human, Humans, male, Middle Aged, neuroleptic agent, outcome assessment, Outcome Assessment (Health Care), phase 2 clinical trial, physiology, Pilot Projects, pilot study, priority journal, procedures, psychotherapy, quality of life, randomized controlled trial, schizophrenia, Speech Perception, symptom, Therapy, therapy delay, therapy effect, treatment duration, treatment response, virtual reality, virtual reality exposure therapy},

pubstate = {published},

tppubtype = {article}

}

@article{berthiaume_validation_2018,

title = {The validation of a telepresence scale for psychotherapy delivered in videoconference},

author = {M. Berthiaume and S. Bouchard and C. Brisebois and G. Robillard},

url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-85067878343&partnerID=40&md5=2f77683267ff320f07e35158fb55b9e4},

issn = {15548716},

year  = {2018},

date = {2018-01-01},

journal = {Annual Review of CyberTherapy and Telemedicine},

volume = {2018},

number = {16},

pages = {131–136},

publisher = {Interactive Media Institute},

abstract = {The Telepresence in Videoconference Scale (TVS) was developed and tested over several years, but its psychometric properties have not been formally documented. The aim of this study was to examine the reliability and factor structure of the TVS. A total of 157 participants completed the scale following a videoconference session with a psychotherapist delivered over four clinical trials. The TVS was submitted to an exploratory factor analysis using the Principal Components method and a Varimax rotation. Three factors were found: ‘’Physical Presence’’, ‘’Interaction’’, and ‘’Absorption’’. Inter-item correlations and Cronbach’s alpha were conducted to measure the internal consistency of the scale. Discriminant validity and convergent validity were assessed with the Immersive Tendencies Questionnaire and the Distance Communication Comfort Scale. The results suggest that this revised version of the Telepresence in Videoconference Scale is a reliable and valid tool to measure clients’ sense of presence during psychotherapy sessions delivered over videoconference technologies. Future research could examine whether this scale may be used in different contexts and with different populations. © 2018, Interactive Media Institute. All rights reserved.},

note = {Publisher: Interactive Media Institute},

keywords = {adult, article, comfort, controlled study, convergent validity, Cronbach alpha coefficient, discriminant validity, exploratory factor analysis, female, human, human experiment, internal consistency, major clinical study, male, psychotherapist, psychotherapy, questionnaire, validation process, varimax rotation, videoconferencing},

pubstate = {published},

tppubtype = {article}

}

@article{katzman_canadian_2014,

title = {Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders},

author = {M. A. Katzman and P. Bleau and P. Blier and P. Chokka and K. Kjernisted and M. Van Ameringen and M. M. Antony and S. Bouchard and A. Brunet and M. Flament and K. Rabheru and S. Grigoriadis and P. M. A. Richter and S. Mendlowitz and K. O'Connor and M. Robichaud and J. R. Walker and G. Asmundson and L. R. Klassen and R. W. Lam and R. S. McIntyre and I. Szpindel},

url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-84903778611&doi=10.1186%2f1471-244X-14-S1-S1&partnerID=40&md5=4787fc6f97c204c1428770a5e4a57a00},

doi = {10.1186/1471-244X-14-S1-S1},

issn = {1471244X (ISSN)},

year  = {2014},

date = {2014-01-01},

journal = {BMC Psychiatry},

volume = {14},

number = {SUPPL.1},

publisher = {BioMed Central Ltd.},

abstract = {Background: Anxiety and related disorders are among the most common mental disorders, with lifetime prevalence reportedly as high as 31%. Unfortunately, anxiety disorders are under-diagnosed and under-treated.Methods: These guidelines were developed by Canadian experts in anxiety and related disorders through a consensus process. Data on the epidemiology, diagnosis, and treatment (psychological and pharmacological) were obtained through MEDLINE, PsycINFO, and manual searches (1980-2012). Treatment strategies were rated on strength of evidence, and a clinical recommendation for each intervention was made, based on global impression of efficacy, effectiveness, and side effects, using a modified version of the periodic health examination guidelines.Results: These guidelines are presented in 10 sections, including an introduction, principles of diagnosis and management, six sections (Sections 3 through 8) on the specific anxiety-related disorders (panic disorder, agoraphobia, specific phobia, social anxiety disorder, generalized anxiety disorder, obsessive-compulsive disorder, and posttraumatic stress disorder), and two additional sections on special populations (children/adolescents, pregnant/lactating women, and the elderly) and clinical issues in patients with comorbid conditions.Conclusions: Anxiety and related disorders are very common in clinical practice, and frequently comorbid with other psychiatric and medical conditions. Optimal management requires a good understanding of the efficacy and side effect profiles of pharmacological and psychological treatments. © 2014 Katzman et al.},

note = {Publisher: BioMed Central Ltd.},

keywords = {agoraphobia, Anxiety disorder, Anxiety Disorders, benzodiazepine derivative, buspirone, Canada, clinical trial, clomipramine, comorbidity, duloxetine, escitalopram, fluoxetine, fluvoxamine, fluvoxamine maleate, GAD, generalized anxiety disorder, guidelines, human, Humans, obsessive compulsive disorder, Obsessive-Compulsive Disorder, OCD, panic, Panic Disorder, paroxetine, periodic medical examination, pharmacotherapy, Post-Traumatic, posttraumatic stress disorder, practice guideline, Practice Guidelines as Topic, psychotherapy, PTSD, recommendations, review, sertraline, social anxiety disorder, social phobia, special populations, Specific phobia, Stress Disorders, venlafaxine},

pubstate = {published},

tppubtype = {article}

}